Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet

v3.19.2
Balance Sheet - USD ($)
Jun. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 5,129,828 $ 6,892,772
Deferred offering costs 371,113 344,936
Other current assets 94,149 80,247
Total current assets 5,595,090 7,317,955
Total assets 5,595,090 7,317,955
Current liabilities:    
Accounts payable, accrued expenses and other current liabilities 468,272 399,551
Total current liabilities 468,272 399,551
Total liabilities 468,272 399,551
Commitments and contingencies (Note 7)
Stockholders' equity:    
Common stock, par value of $0.001 per share, 40,000,000 shares authorized, 9,291,421 shares issued and outstanding at June 30, 2019 and December 31, 2018 9,291 9,291
Additional paid-in capital 29,058,630 28,567,221
Accumulated deficit (3,456) (2,396)
Accumulated other comprehensive loss (23,937,647) (21,655,712)
Total stockholders' equity 5,126,818 6,918,404
Total liabilities and stockholders' equity $ 5,595,090 $ 7,317,955